The utility of combined mutation analysis and microRNA classification in reclassifying cancer risk of cytologically indeterminate thyroid nodules
ConclusionsMutation panels alone do not sufficiently risk stratify thyroid nodular disease. microRNA classification complements cytology and mutation analysis with the capacity to better differentiate nodules at high risk of malignancy.
Source: Diagnostic Cytopathology - Category: Pathology Authors: Anna B. Banizs,
Jan F. Silverman Tags: ORIGINAL ARTICLE Source Type: research